SCHEMBL20122551

SCHEMBL20122551

CCOC(=O)[C@H](CSC(=O)OCOC(=O)CC)NC(=O)C(C)(C)SC(=O)OCOC(=O)CC

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ ALDH1A1 P00352 3/20 0.32
▸ MAPT P10636 3/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ POLB P06746 1/20 0.32
▸ CAD P27708 1/20 0.30
▸ METAP2 P50579 1/20 0.30
▸ METAP1 P53582 1/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ GAA P10253 1/20 0.30
▸ PKM P14618 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ ALOX12 P18054 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20122545 0.91 CYP1A2 (0.31) CYP1A2CYP2C9CYP2C19HTT
SCHEMBL20122592 0.91 CYP1A2 (0.32) CYP1A2CYP2C9CYP2C19HTT
SCHEMBL20122396 0.90 CYP1A2 (0.38) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL20122546 0.89 CYP1A2 (0.37) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL20122523 0.89 CYP1A2 (0.37) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL20122591 0.89 CYP1A2 (0.37) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL20122444 0.89 CYP1A2 (0.31) CYP1A2CYP2C9CYP2C19HTT
SCHEMBL20122550 0.88 — —
SCHEMBL20122387 0.84 PPARA (0.37) CYP1A2CYP2C9CYP2C19POLB
SCHEMBL20122520 0.84 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963428-B1 Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of use Nguyen, Mark Quang (US) 2018-05-08 — — US disclosed
Send feedback